Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Absence of interference of serum IgGs from patients with breast cancer and thyroid autoimmunity on the function of human iodide symporter gene stably transfected in CHO cells.

Fierabracci P, Pinchera A, Tonacchera M, Agretti P, De Marco G, Albertini S, Conforti G, Seregni E, Agresti R, Grasso L, Giani C.

J Endocrinol Invest. 2004 Oct;27(9):862-5.

PMID:
15648551
2.

The sodium iodide symporter is unlikely to be a thyroid/breast shared antigen.

Muller I, Zhang L, Giani C, Dayan CM, Ludgate ME, Grennan-Jones F.

J Endocrinol Invest. 2016 Mar;39(3):323-31. doi: 10.1007/s40618-015-0368-6. Epub 2015 Aug 8.

PMID:
26253711
3.

Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.

Tonacchera M, Agretti P, Ceccarini G, Lenza R, Refetoff S, Santini F, Pinchera A, Chiovato L, Vitti P.

Eur J Endocrinol. 2001 Jun;144(6):611-8.

4.

Association between breast cancer and autoimmune thyroid disorders: no increase of lymphocytic infiltrates in breast malignant tissues.

Fierabracci P, Pinchera A, Campani D, Pollina LE, Giustarini E, Giani C.

J Endocrinol Invest. 2006 Mar;29(3):248-51.

PMID:
16682839
5.

Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis.

Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A.

J Clin Endocrinol Metab. 1993 Dec;77(6):1700-5.

PMID:
7903315
6.

Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.

Ajjan RA, Kemp EH, Waterman EA, Watson PF, Endo T, Onaya T, Weetman AP.

J Clin Endocrinol Metab. 2000 May;85(5):2020-7.

PMID:
10843191
7.

Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.

Endo T, Kaneshige M, Nakazato M, Kogai T, Saito T, Onaya T.

Biochem Biophys Res Commun. 1996 Nov 1;228(1):199-202.

PMID:
8912659
8.

The modulation of the human sodium iodide symporter activity by Graves' disease sera.

Ajjan RA, Findlay C, Metcalfe RA, Watson PF, Crisp M, Ludgate M, Weetman AP.

J Clin Endocrinol Metab. 1998 Apr;83(4):1217-21.

PMID:
9543144
9.

Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.

Agretti P, Dimida A, De Marco G, Ferrarini E, Rodrìguez Gonzàlez JC, Santini F, Vitti P, Pinchera A, Tonacchera M.

J Endocrinol Invest. 2011 Mar;34(3):170-4. doi: 10.3275/7046. Epub 2010 May 17.

PMID:
20479570
10.

Does thyroid peroxidase provide an antigenic link between thyroid autoimmunity and breast cancer?

Muller I, Giani C, Zhang L, Grennan-Jones FA, Fiore E, Belardi V, Rosellini V, Funel N, Campani D, Giustarini E, Lewis MD, Bakhsh AD, Roncella M, Ghilli M, Vitti P, Dayan CM, Ludgate ME.

Int J Cancer. 2014 Apr 1;134(7):1706-14. doi: 10.1002/ijc.28493. Epub 2013 Oct 15.

11.

Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).

Chin HS, Chin DK, Morgenthaler NG, Vassart G, Costagliola S.

J Clin Endocrinol Metab. 2000 Oct;85(10):3937-40.

PMID:
11061560
12.

Tissue iodine content and serum-mediated 125I uptake-blocking activity in breast cancer.

Kilbane MT, Ajjan RA, Weetman AP, Dwyer R, McDermott EW, O'Higgins NJ, Smyth PP.

J Clin Endocrinol Metab. 2000 Mar;85(3):1245-50.

PMID:
10720070
13.

[Effect of iodine and thyroid hormones in the induction and therapy of Hashimoto's thyroiditis].

Rink T, Schroth HJ, Holle LH, Garth H.

Nuklearmedizin. 1999;38(5):144-9. German.

PMID:
10488481
14.

Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.

Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.

Acta Med Austriaca. 1996;23(1-2):52-6.

PMID:
8767515
15.

Uptake of amiodarone by thyroidal and non-thyroidal cell lines.

Bogazzi F, Raggi F, Ultimieri F, Russo D, Cosci C, Cecchetti P, Dell'Unto E, Sardella C, Tonacchera M, Vitti P, Benzi L, Bartalena L, Martino E.

J Endocrinol Invest. 2006 Jan;29(1):61-6.

PMID:
16553035
16.

Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery.

Giustarini E, Pinchera A, Fierabracci P, Roncella M, Fustaino L, Mammoli C, Giani C.

Eur J Endocrinol. 2006 May;154(5):645-9.

17.

Autoimmunity involving the human sodium/iodide symporter: fact or fiction?

Heufelder AE, Joba W, Morgenthaler NG.

Exp Clin Endocrinol Diabetes. 2001;109(1):35-40. Review.

PMID:
11573137
18.

Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.

Kogai T, Taki K, Brent GA.

Endocr Relat Cancer. 2006 Sep;13(3):797-826. Review.

19.

Effects of thyroid status on thyroid autoimmunity expression in euthyroid and hypothyroid patients with Hashimoto's thyroiditis.

Rieu M, Richard A, Rosilio M, Laplanche S, Ropion V, Fombeur JP, Berrod JL.

Clin Endocrinol (Oxf). 1994 Apr;40(4):529-35.

PMID:
8187321
20.

Distribution of immunoglobulin G subclasses of anti-thyroid peroxidase antibody in sera from patients with Hashimoto's thyroiditis with different thyroid functional status.

Xie LD, Gao Y, Li MR, Lu GZ, Guo XH.

Clin Exp Immunol. 2008 Nov;154(2):172-6. doi: 10.1111/j.1365-2249.2008.03756.x. Epub 2008 Sep 5.

Supplemental Content

Support Center